Biography
Andrea Burden obtained her Bachelor of Science degree in Psychology and a Master of Arts in Criminology at the University of Toronto.
Following her Master’s program Andrea enrolled in a Master of Science in the faculty of pharmaceutical sciences at the University of Toronto, with focus in pharmacoepidemiology (drug safety and effectiveness). Following 18-months in the MSc program, she transferred to the PhD stream where her research focus was on osteoporosis medication adherence.
In 2014, she received a CIHR fellowship (2015-2017) to conduct her postdoctoral research in the Netherlands, where her focus is on diabetes and bone health and rheumatoid arthritis. Since 2018 she is an Assistant Professor at ETH Zurich where she holds the chair in pharmacoepidemiology at the Institute of Pharmaceutical Sciences.
Andrea has experience analysing some of the world’s most prestigious healthcare databases from Canada, the UK, Denmark and the Netherlands.
Her primary research line examines the safety and effectiveness of medications in chronic disease management, with particular focus on the relationship between metabolic (diabetes and obesity) and musculoskeletal (osteoporosis and rheumatoid arthritis) diseases.
List of 5 Best Publications
Identification of Medication Prescription Errors and Factors of Clinical Relevance in 314 Hospitalized Patients for Improved Multidimensional Clinical Decision Support Algorithms
https://pubmed.ncbi.nlm.nih.gov/37568322/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acJAK-inhibitors and risk on serious viral infection, venous thromboembolism and cardiac events in patients with rheumatoid arthritis: A protocol for a prevalent new-user cohort study using the Danish nationwide DANBIO register
https://pubmed.ncbi.nlm.nih.gov/37498856/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acDesign and Execution of Sustainable Decentralized Clinical Trials
https://pubmed.ncbi.nlm.nih.gov/37489911/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acObesity Represents a Persisting Health Issue in Axial Spondyloarthritis, Particularly Affecting Socially Disadvantaged Patients
https://pubmed.ncbi.nlm.nih.gov/37453738/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acPatient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs
https://pubmed.ncbi.nlm.nih.gov/37267387/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acAn explorative analysis of pharmacovigilance data of oxytocin and its analogue carbetocin, with a focus on haemodynamic adverse effects
https://pubmed.ncbi.nlm.nih.gov/37162656/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acCancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study
https://pubmed.ncbi.nlm.nih.gov/37052534/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acComparison of Fracture Identification Using Different Definitions in Healthcare Administrative (Claims) Data
https://pubmed.ncbi.nlm.nih.gov/36961031/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acSite-Specific Fracture Incidence Rates Among Patients With Type 1 Diabetes, Type 2 Diabetes, or Without Diabetes in Denmark (1997-2017)
https://pubmed.ncbi.nlm.nih.gov/36696428/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acIdentification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining
https://pubmed.ncbi.nlm.nih.gov/36579709/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acThe associations between bariatric surgery and hip or knee arthroplasty, and hip or knee osteoarthritis: Propensity score-matched cohort studies
https://pubmed.ncbi.nlm.nih.gov/36475281/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acComorbidity clusters associated with newly treated type 2 diabetes mellitus: a Bayesian nonparametric analysis
https://pubmed.ncbi.nlm.nih.gov/36450743/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acLower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort
https://pubmed.ncbi.nlm.nih.gov/36264948/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acMinimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort
https://pubmed.ncbi.nlm.nih.gov/36115672/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acOpioid sales and opioid-related poisonings in Switzerland: A descriptive population-based time-series analysis
https://pubmed.ncbi.nlm.nih.gov/36090669/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acUse of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study
https://pubmed.ncbi.nlm.nih.gov/35842030/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acFracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review
https://pubmed.ncbi.nlm.nih.gov/35578134/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acIdentification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection
https://pubmed.ncbi.nlm.nih.gov/35551258/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acComment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study
https://pubmed.ncbi.nlm.nih.gov/35531047/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acCorrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
https://pubmed.ncbi.nlm.nih.gov/35370960/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acInterruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland
https://pubmed.ncbi.nlm.nih.gov/35292498/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acBiological Disease-Modifying Antirheumatic Drugs and Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis: A Danish Cohort Study
https://pubmed.ncbi.nlm.nih.gov/35134369/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acBone fragility in diabetes: novel concepts and clinical implications
https://pubmed.ncbi.nlm.nih.gov/35101185/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acDrug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients
https://pubmed.ncbi.nlm.nih.gov/35054090/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acWhen to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
https://pubmed.ncbi.nlm.nih.gov/34975756/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acFracture Patterns in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review of Recent Literature
https://pubmed.ncbi.nlm.nih.gov/34931295/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acObservational cross-sectional case study of toxicities of antifungal drugs
https://pubmed.ncbi.nlm.nih.gov/34896339/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acPrediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients
https://pubmed.ncbi.nlm.nih.gov/34888435/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acThe association between bariatric surgery and cataract: a propensity score-matched cohort study
https://pubmed.ncbi.nlm.nih.gov/34863672/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acThe association of bariatric surgery and Dupuytren's disease: a propensity score-matched cohort study
https://pubmed.ncbi.nlm.nih.gov/34851767/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acCommunity Pharmacist-Administered COVID-19 Vaccinations: A Pilot Customer Survey on Satisfaction and Motivation to Get Vaccinated
https://pubmed.ncbi.nlm.nih.gov/34835251/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acExternal validation of the PAR-Risk Score to assess potentially avoidable hospital readmission risk in internal medicine patients
https://pubmed.ncbi.nlm.nih.gov/34813625/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acIncreased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis
https://pubmed.ncbi.nlm.nih.gov/34702319/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acA Network Analysis of Drug Combinations Associated with Acute Generalized Exanthematous Pustulosis (AGEP)
https://pubmed.ncbi.nlm.nih.gov/34640505/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acClinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients
https://pubmed.ncbi.nlm.nih.gov/34361984/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acComparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland
https://pubmed.ncbi.nlm.nih.gov/34300360/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acLow-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink
https://pubmed.ncbi.nlm.nih.gov/34255815/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acAssessment of minor health disorders with decision tree-based triage in community pharmacies
https://pubmed.ncbi.nlm.nih.gov/34244075/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acThiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study
https://pubmed.ncbi.nlm.nih.gov/34129693/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acResponse to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study' by Gong and Zhang and Lin et al
https://pubmed.ncbi.nlm.nih.gov/34039619/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acCardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)
https://pubmed.ncbi.nlm.nih.gov/33924496/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acDeterminants of treatment modification before and after implementation of the updated 2015 NICE guideline on type 2 diabetes: A retrospective cohort study
https://pubmed.ncbi.nlm.nih.gov/33894280/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acGlobal adverse events reported for direct-acting antiviral therapies for the treatment of hepatitis C: an analysis of the World Health Organization VigiBase
https://pubmed.ncbi.nlm.nih.gov/33883523/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acPrimary and secondary non-response: in need of operational definitions in observational studies
https://pubmed.ncbi.nlm.nih.gov/33883161/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acDuration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making
https://pubmed.ncbi.nlm.nih.gov/33803095/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acResponse to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'' by Zheng
https://pubmed.ncbi.nlm.nih.gov/33558257/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acRenal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data
https://pubmed.ncbi.nlm.nih.gov/33341923/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acConcomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study
https://pubmed.ncbi.nlm.nih.gov/33310727/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acOsteoporosis case ascertainment strategies in European and Asian countries: a comparative review
https://pubmed.ncbi.nlm.nih.gov/33305343/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293acImplementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice
https://pubmed.ncbi.nlm.nih.gov/33242107/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20230922134822&v=2.17.9.post6+86293ac